2
102
5
| Cat. No. | Product Name | ||
|---|---|---|---|
| CL0046 | 5-HT Receptor antagonist/agonist kit | ||
| L1710 | 抗COVID-19化合物库 | 1160 compounds | |
| A unique collection of 1160 compounds with confirmed anti-SARS-CoV-2 activity or potential activity and part of them are broad-spectrum antiviral agents； | |||
| DP1100 | 钠离子通道阻滞剂/拮抗剂库 | ||
| L6720 | 抗COVID-19中药单体库 | 1162 compounds | |
| A unique collection of 1162 monomers from 60 TCM plants, a powerful tool for anti-COVID-19 drug discovery, can be used for HTS and HCS screening； | |||
| CL0073 | DNA synthesis inhibitor/activator kit | ||
| CL0056 | CDK inhibitor kit | ||
| L7110 | 抗高血压化合物库 | 719 compounds | |
| 719 hypertension-related small molecules for high-throughput and high-content screening. | |||
| L6730 | 抗病毒中药单体化合物库 | 270 compounds | |
| A collection of 270 TCM monomers with anti-virus activity. An effective tool for drug development and pharmacological studies. | |||
| L1700 | 抗病毒库 | 800 compounds | |
| A unique collection of 800 anti-virus compounds effective for new anti-virus drugs high throughput screening and high content screening; | |||
| L8800 | 药物片段库 | 1158 compounds | |
| 1158 drug fragments，a must-have tool for FBDD; | |||
| L5610 | Golden骨架库 | 10000 compounds | |
| Diversity: Selected from 1,600,000 drug-like compounds, 10000compounds representing 5000 scaffolds selected from a large drug-like chemical source； | |||
| CL0058 | EGFR inhibitor kit | ||
| L7100 | 抗肥胖化合物库 | 1359 compounds | |
| A unique collection of 1359 anti-obesity compounds for high throughput and high content screening; | |||
| L1800 | 抗感染化合物库 | 2977 compounds | |
| A unique collection of 2977 anti-infective compounds including anti-bacterial, anti-fungi, anti-Human Cytomegalovirus (HCMV), anti-HIV, anti-SARS, anti-influenza, etc; | |||
| L5100 | 含氟化合物库 | 583 compounds | |
| A unique collection of 583 fluorochemicals that can be used for high through-put screening (HTS) and high content screening (HCS); | |||
| DO1200 | 药物靶点库 | ||
| DP9200 | DGK抑制剂库 | ||
| L8500 | HIF-1化合物库 | 1352 compounds | |
| A unique collection of 1352 HIF-1 related small chemicals can be used for drug discovery in ischemic disease and cancer and related mechanism studies； | |||
| DF4500 | 多样性核心库Part1 | ||
| VM1400 | 多样性核心库Part2 | ||
| L6210 | 藏药化合物库 | 754 compounds | |
| A collection of 754 natural product molecules originated from Tibetan medicine, which can be used for high-throughput and high-content screening. | |||
| L7700 | 神经再生化合物库 | 529 compounds | |
| A unique collection of 149 neuroregeneration related compounds for high throughput and high content screening; | |||
| L4710 | 非甾体类抗炎化合物库 | 530 compounds | |
| 530 non-steroidal anti-inflammatory compounds for high-throughput and high-content screening. | |||
| L3510 | 甲基化化合物库 | 131 compounds | |
| 131 methylation-related compounds that can be used for high-throughput and high-content screening. | |||
| L1580 | GPCR库Plus | 338 compounds | |
| Well-chosen 338 GPCR targeting compounds with unique structures; | |||
| L6300 | 药食同源库 | 1088 compounds | |
| A unique collection of 1088 compounds from food as medicine for high throughput and high content screening; | |||
| L9420 | 外泌体相关化合物库 | 54 compounds | |
| 54 exosome-related compounds that can be used for high-throughput and high-content screening. | |||
| L1500 | GPCR靶点分子库 | 1633 compounds | |
| A unique collection of 1633 GPCR-active agents for high throughput screening and high content screening for GPCR drug discovery, and new GPCR target identification and research; | |||
| L2190 | 抗肺癌化合物库 | 1735 compounds | |
| A unique collection of 1735 compounds with anti-lung cancer therapeutic activity or targeting lung cancer’s major signaling pathways, can be used for anti-lung cancer drug discovery and mechanism study； | |||
| L2191 | 抗乳腺癌化合物库 | 1965 compounds | |
| A unique collection of 1965 compounds with anti-breast cancer therapeutic activity or targeting breast cancer’s major signaling pathways, can be used for anti-breast cancer drug discovery and mechanism study； | |||
| L2130 | 抗癌细胞代谢库 | 1280 compounds | |
| A unique collection of 1280 cancer cellular metabolism related compounds for cancer research and high throughput screening (HTS) and high content screening (HCS); | |||
| CL0139 | ROS inhibitor kit | ||
| L4500 | 抗真菌库 | 253 compounds | |
| A unique collection of 253 antifungal compounds effective for drug repurposing screening, combination screening and biological investigation. | |||
| L6220 | 蒙药化合物库 | 960 compounds | |
| A collection of 960 natural product molecules originated from Mongolian medicine, which can be used for high-throughput and high-content screening. | |||
| L2180 | 抗肿瘤库Plus | 1468 compounds | |
| Well-chosen 1468 anti-tumor compounds with unique structures; | |||
| L9410 | 共价抑制剂库 | 941 compounds | |
| A unique collection of 941 covalent Inhibitors and other molecules with common warheads like chloroacetyl，2-Chloropropionyl，Acryloyl，sulfonyl fluoride, alkyne，acrylamide, ketocarbonyl，disulfide bond, etc. | |||
| L5800 | 药物代谢杂质库 | 200 compounds | |
| A unique collection of 200 drug isomers/metabolites for high throughput screening (HTS) and high content screening (HCS); | |||
| L7300 | 钾通道分子库 | 160 compounds | |
| A unique collection of 160 potassium channel blockers and agonists for high throughput and high content screening; | |||
| L2620 | 神经退行性疾病化合物库 | 1622 compounds | |
| A unique collection of 1622 compounds related to neurodegenerative diseases can be used for HTS or HCS； | |||
| L9700 | 内质网应激化合物库 | 193 compounds | |
| A unique collection of 193 endoplasmic reticulum stress (ER stress) related compounds used for high throughput screening (HTS) and high content screening (HCS); | |||
| L9830 | 抗帕金森病化合物库 | 908 compounds | |
| A unique collection of 908 compounds with anti-PD activities or acting on main drug targets of PD can be used for HTS and HCS. | |||
| L9200 | 药物功能重定位化合物库 | 4240 compounds | |
| A unique collection of 4240 approved and clinical drugs for high throughput screening (HTS) and high content screening (HCS); | |||
| L8110 | 细胞重编程化合物库 | 1840 compounds | |
| A unique collection of 1840 reprogramming signaling pathway-related bioactive small molecule compounds for high-throughput, high-content screening. | |||
| L6810 | 中药单体化合物库 | 2688 compounds | |
| A unique collection of 2688 compounds (TCM monomers) sourcing from traditional Chinese Medicines, is a powerful tool for drug discovery and research in mechanism； | |||
| L9230 | ReFRAME 相关化合物库 | 3274 compounds | |
| A unique collection of 3274 compounds for high-throughput screening and high-content screening, | |||
| L7860 | Mini片段亲电杂环化合物库 | 369 compounds | |
| 369 compounds in total in the Highly Solubility Covalent Heterocyclic Fragment Library | |||
| L8400 | 血液病分子库 | 524 compounds | |
| A unique collection of 524 compounds related to hematologic diseases for high throughput screening (HTS) and high content screening (HCS); | |||
| L7830 | 高溶解性片段药效团化合物库 | 985 compounds | |
| High Solubility Pharmacophore Fragment library contains 985 fragment small molecules. | |||
| L6120 | 黄酮类天然产物库 | 477 compounds | |
| A unique collection of 477 flavonoids can be used for high throughput and high content screening； | |||
| L2540 | 肠道微生物代谢化合物库 | 352 compounds | |
| A unique collection of 352 gut microbial metabolites which can be used for HTS and HCS; | |||
| L2520 | 糖代谢化合物库 | 708 compounds | |
| 708 glycometabolism-related comounds, can be used for HTS and HCT; | |||
| L1000 | 上市药物库 | 2863 compounds | |
| A unique collection of 2863 approved drugs for high throughput screening (HTS) and high content screening (HCS); | |||
| L5700 | 精选片段库 | 246 compounds | |
| A unique collection of 246 fragment-like small molecules for FBDD; | |||
| L6010 | 天然产物库 | 3720 compounds | |
| A unique collection of 3720 natural products for high throughput screening (HTS) and high content screening (HCS); | |||
| L4510 | 抗寄生虫库 | 336 compounds | |
| 336 well-chosen unique anti-parasitic small molecules; | |||
| L4660 | 神经疾病库Plus | 1246 compounds | |
| Well-chosen 1246 compounds with unique structures targeting nervous system; | |||
| L3900 | DNA 损伤和修复分子库 | 937 compounds | |
| A unique collection of 937 DNA Damage & Repair related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
| NY1000 | 天然产物衍生物库 | 4000 compounds | |
| The library consists of more than 4,000 members belonging 22 scaffolds (average 180 compounds per scaffold). | |||
| L9400 | PPI抑制剂库 | 260 compounds | |
| A unique collection of 260 PPI-related compounds for drug screening; | |||
| L2000 | 抑制剂库 | 7618 compounds | |
| A unique collection of 7618 inhibitors for research in cell signaling, high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
| L1010 | FDA上市及药典收录分子库 | 3158 compounds | |
| 3158个上市及药典分子集合，可用于高通量筛选和高内涵筛选； | |||
| L6800 | 中国药典收录天然产物库 | 2070 compounds | |
| A unique collection of 2070 natural products included in Chinese Pharmacopoeia (CP), a powerful tool for drug development and pharmacological study; | |||
| L3200 | 自噬库 | 1248 compounds | |
| A unique collection of 1248 compounds with defined autophagy-inducing or -inhibitory activity for research in autophagy, high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
| L3980 | DNA损伤/修复库Plus | 667 compounds | |
| Well-chosen 667 compounds with unique structures targeting DNA damage & repair; | |||
| L6030 | 天然产物衍生物虚筛化合物库 | ||
| L1200 | 表观遗传库 | 960 compounds | |
| Well-chosen 960 compounds related to epigenetic regulation for research in epigenetics, high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
| L2192 | 抗胰腺癌化合物库 | 2267 compounds | |
| A unique collection of 2267 pancreatic cancer related compounds can be used in HTS and HCS; | |||
| L3600 | 细胞因子抑制剂库 | 613 compounds | |
| A unique collection of 613 compounds targeting cytokine signaling for high throughput screening and high content screening for drug discovery; | |||
| L1610 | FDA 上市激酶抑制剂库 | 280 compounds | |
| Targetmol’s FDA-Approved Kinase Inhibitor Library contains 280 marketed drugs with proven kinase inhibitory activity. These kinases include Insulin/IGF Receptors、PI 3-Kinase、CaM Kinase II、JAK、PKA、CDK、JNK、PKC、CKI II、MAPK、RAF、EGFR、MEK、SAPK、GSK、MLCK、Src-family、IKK、PDGFR、VEGFR etc. FDA-Approved Kinase Inhibitor Library is a powerful tool for kinase drug development and related research. | |||
| L2521 | 糖酵解化合物库 | 560 compounds | |
| 560 glycolysis-related active compounds for high-throughput and high-content screening. | |||
| L8600 | 泛素化化合物库 | 214 compounds | |
| A unique collection of 214 ubiquitination related small chemicals can be used for high throughput and high content screening； | |||
| L8700 | 铁死亡化合物库 | 800 compounds | |
| A unique collection of 800 ferroptosis signaling pathway related compounds, a powerful tool for new target identification, drug discovery, and mechanism study； | |||
| L9850 | 口服活性化合物库 | 2484 compounds | |
| A unique collection of 2484 of orally active compounds for high-throughput screening and high-content screening. | |||
| L2800 | 5-羟色胺分子库 | 275 compounds | |
| A unique collection of 275 compounds targeting serotonin receptors for high throughput screening and high content screening; | |||
| L8710 | 铜死亡化合物库 | 411 compounds | |
| TargetMol’s Cuproptosis Compound Library is a collection of 411 compounds related to copper-dependent death that can be used to study its mechanism and related diseases. | |||
| L1120 | AMPK靶向分子库 | 64 compounds | |
| 64 well-chosen unique AMPK-targeted small molecules； | |||
| L4800 | 血管生成库 | 1370 compounds | |
| A unique collection of 1370 proangiogenic and antiangiogenic compounds for new targets identification, research in mechanisms of angiogenesis, and high throughput screening (HTS) and high content screening (HCS); | |||
| L9210 | 儿童药物库 | 1015 compounds | |
| A unique collection of 1015 pediatric drugs for high-throughput screening and high-content screening. | |||
| L6110 | 生物碱类天然产物库 | 468 compounds | |
| A unique collection of 468 natural alkaloids can be used for high throughput and high content screening； | |||
| L7500 | 凝血与抗凝化合物库 | 154 compounds | |
| A unique collection of 154 procoagulation and anticoagulation related compounds for high throughput screening (HTS) and high content screening (HCS); | |||
| L9860 | 抗抑郁症化合物库 | 1181 compounds | |
| 1181 compounds associated with depression that can be used for high-throughput and high-content screening | |||
| L2600 | 神经信号分子库 | 2011 compounds | |
| A unique collection of 2011 compounds targeting CNS signaling for high throughput screening (HTS) and high content screening (HCS) for new drugs; | |||
| L9000 | 细胞凋亡化合物库 | 1796 compounds | |
| A unique collection of 1796 apoptosis-related compounds for apoptosis research, research in tumorigenesis, and anti-cancer drug screening; | |||
| L6700 | 抗癌天然产物库 | 1800 compounds | |
| A unique collection of 1800 natural products with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS); | |||
| L2500 | 人内源代谢化合物库 | 1400 compounds | |
| A unique collection of 1400 endogenous metabolism-related compounds for research in endogenous metabolism-related diseases and drug screening; | |||
| L2140 | 癌细胞分化化合物库 | 413 compounds | |
| A unique collection of 413 cancer cell differentiation inducing compounds for high throughput and high content screening; | |||
| L4010 | 已知活性化合物库 | 20980 compounds | |
| A collection of 20980 bioactive compounds for high-throughput screening, high-content screening, cell induction and target identification. | |||
| L2194 | 抗结直肠癌化合物库 | 1565 compounds | |
| 1565 compounds associated with colorectal cancer that can be used for high-throughput and high-content screening. | |||
| L6200 | 瑶药化合物库 | 225 compounds | |
| A collection of 225 natural product molecules originated from Yao medicine, which can be used for high-throughput and high-content screening. | |||
| L2510 | 脂代谢化合物库 | 496 compounds | |
| A unique collection of 496 compounds targeting lipid metabolism, can be used for high-throughput screening (HTS) and high-content screening (HCS). | |||
| L9600 | 多肽分子库 | 533 compounds | |
| 533 peptides can be used in peptide drug development and signaling transduction and mechanism study; | |||
| L2610 | 神经递质受体化合物库 | 1513 compounds | |
| A unique collection of 1513 neurotransmitter receptor compounds, can be used for HTS and HCS screening； | |||
| L4700 | 免疫/炎症分子化合物库 | 3483 compounds | |
| A unique collection of 3483 anti-inflammation compounds effective for high throughput screening and high content screening. | |||
| L4600 | 植物来源化合物库 | 3076 compounds | |
| A unique collection of 3076 plant-sourced compounds that derived from 277 plant species for high throughput screening (HTS) and high content screening (HCS); | |||
| L6000 | 高通量筛选天然产物库 | 4320 compounds | |
| A unique collection of 4320 pure natural products and their derivatives with known biological activity for drug discovery, pharmacological study, stem cell differentiation, fingerprint study and quality research, and can be used for high throughput screen | |||
| L6400 | 海洋天然产物库 | 94 compounds | |
| A unique collection of 94 marine natural products for high throughput screening (HTS) and high content screening (HCS); | |||
| L2170 | 肿瘤免疫治疗小分子化合物库 | 454 compounds | |
| A unique collection of 454 compounds acting on immune-oncology therapeutic targets can be used for high throughput and high content screening； | |||
| L9840 | 抗阿尔茨海默症化合物库 | 1040 compounds | |
| A unique collection of 1040 compounds with anti-AD activities or acting on main drug targets of AD can be used for HTS and HCS. | |||
| L9300 | 大环化合物库 | 216 compounds | |
| 216种活性已知的大环化合物，用于高通量、高内涵筛选； | |||
| L6740 | 抗结直肠癌中药单体化合物库 | 386 compounds | |
| A collection of 386 TCM monomers with anti-colorectal activity. An effective tool for drug development and pharmacological studies. | |||
| DC1010 | 特权片段注释化合物库-GPCR Family A | ||
| DP1300 | h-TERT靶向化合物库 | ||
| Cat. No. | Product Name | Form | Specificity Of Inhibition |
|---|---|---|---|
| C0003 |
Phosphatase Inhibitor Cocktail II (100× DMSO)
磷酸酶抑制剂 Cocktail II |
Solution (100× in DMSO) | Alkaline phosp<em><em>ha</em></em>tases, Ser/Thr phosp<em><em>ha</em></em>tases, Acid and PP1 and PP2A |
| C0002 |
Phosphatase Inhibitor Cocktail I (100× ddH2O)
磷酸酶抑制剂 Cocktail I |
Solution (100× in ddH2O) | Acid Phosp<em><em>ha</em></em>tase, Alkaline phosp<em><em>ha</em></em>tase, PTPs, ATPases |
| C0004 |
Phosphatase Inhibitor Cocktail III (2 Tubes, 100x)
磷酸酶抑制剂 Cocktail III |
2 Tube Solution (100×) | Each Tube <em><em>ha</em></em>s different specificity of inhibition |
| C0001 |
Protease Inhibitor Cocktail
蛋白酶抑制剂 Cocktail |
Solution (EDTA-Free,100× in DMSO) | Serine proteases, Aminopeptidases, Cysteine proteases, Aspartic proteases |
| C0045 |
RIPA Lysis Buffer (Strong)
RIPA Lysis Buffer (Strong) |
| Cat. No. | Product Name | Target | Signaling Pathways |
|---|---|---|---|
| T38719L | Influenza HA (110-119) acetate | Others | Others |
| Influenza HA (110-119) acetate is the 110-119 fragment of influenza virus hemagglutinin that can stimulate Treg cells proliferation[1][2]. | |||
| T38719 | Influenza HA (110-119) | ||
| Influenza HA (110-119) is the 110-119 fragment of influenza virus hemagglutinin that can stimulate Treg cells proliferation. | |||
沪公网安备 31010602006700号
